AstraZeneca launches Phase III THARROS trial for BREZTRI in COPD to assess cardiopulmonary outcomes

Silence Therapeutics reports positive 36-week data for Zerlasiran in Phase 2 study for high lipoprotein(a)

Ionis Pharmaceuticals names new executive vice president, chief global product strategy officer

Hyperfine Inc and Athletic Heart collaborate to deliver portable brain imaging for former athletes

Feedback's Bleepa-CareLocker to pioneer digital pathways in UK private healthcare with Medical Imaging partnership

Ionis Pharmaceuticals' Olezarsen receives US FDA Orphan Drug designation for familial chylomicronemia syndrome

Rocket Pharmaceuticals announces extension of FDA Priority Review period on KRESLADI for severe LAD-I treatment

CSL reveals top-line outcome from Phase three AEGIS-II trial of CSL112

Ionis and AstraZeneca's eplontersen granted FDA Fast Track designation for transthyretin-mediated amyloid cardiomyopathy

AstraZeneca invests USD300m to expand US manufacturing for cell therapy

Innovent Biologics announces CFO transition

PrepMD receives accreditation for online healthcare training programs for Nursing Continuing Education Units

Cardio Diagnostics appoints Dr Vimal Ramjee as Strategic Advisor

Acticor Biotech reports positive ACTIMIS clinical study results in Lancet Neurology Journal

Sarepta Therapeutics commences Phase 3 clinical study of SRP-9003 for LGMD2E